UnitedHealth (UNH) | Financial Analysis & Statements
UnitedHealth Group Incorporated Mega-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
113.2B
Gross Profit
18.5B
16.34%
Operating Income
380.0M
0.34%
Net Income
218.0M
0.19%
EPS (Diluted)
$0.01
Balance Sheet Metrics
Total Assets
309.6B
Total Liabilities
207.9B
Shareholders Equity
101.7B
Debt to Equity
2.04
Cash Flow Metrics
Operating Cash Flow
1.3B
Free Cash Flow
160.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
UnitedHealth Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 447.6B | 400.3B | 367.5B | 322.1B | 285.3B |
| Cost of Goods Sold | 364.6B | 310.9B | 280.7B | 244.5B | 217.9B |
| Gross Profit | 82.9B | 89.4B | 86.9B | 77.6B | 67.3B |
| Gross Margin % | 18.5% | 22.3% | 23.6% | 24.1% | 23.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | 59.6B | 53.0B | 54.6B | 47.8B | 42.6B |
| Total Operating Expenses | 59.6B | 53.0B | 54.6B | 47.8B | 42.6B |
| Operating Income | 19.0B | 32.3B | 28.3B | 26.4B | 21.6B |
| Operating Margin % | 4.2% | 8.1% | 7.7% | 8.2% | 7.6% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 4.0B | 3.9B | 3.2B | 2.1B | 1.7B |
| Other Non-Operating Income | -265.0M | -8.3B | 4.1B | 2.0B | 2.3B |
| Pre-tax Income | 14.7B | 20.1B | 29.1B | 26.3B | 22.3B |
| Income Tax | 1.9B | 4.8B | 6.0B | 5.7B | 4.6B |
| Effective Tax Rate % | 12.9% | 24.1% | 20.5% | 21.7% | 20.5% |
| Net Income | 12.8B | 15.2B | 23.1B | 20.6B | 17.7B |
| Net Margin % | 2.9% | 3.8% | 6.3% | 6.4% | 6.2% |
| Key Metrics | |||||
| EBITDA | 23.3B | 36.4B | 32.2B | 29.8B | 24.7B |
| EPS (Basic) | $13.31 | $15.74 | $24.12 | $21.54 | $18.33 |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 |
| Basic Shares Outstanding | 905838620 | 915000000 | 928000000 | 934000000 | 943000000 |
| Diluted Shares Outstanding | 905838620 | 915000000 | 928000000 | 934000000 | 943000000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
UnitedHealth Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 24.4B | 25.3B | 25.4B | 23.4B | 21.4B |
| Short-term Investments | 3.8B | 3.8B | 4.2B | 4.5B | 2.5B |
| Accounts Receivable | 23.0B | 22.4B | 21.3B | 17.7B | 14.2B |
| Inventory | - | - | - | - | - |
| Other Current Assets | 9.7B | 8.2B | 9.8B | 10.7B | 9.8B |
| Total Current Assets | 90.6B | 85.8B | 78.4B | 69.1B | 61.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 241.5B | 236.7B | 222.7B | 201.1B | 161.6B |
| Intangible Assets | 20.5B | 23.3B | 15.2B | 14.4B | 10.0B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 23.0B | 19.6B | 17.3B | 15.0B | 12.5B |
| Total Non-Current Assets | 219.0B | 212.5B | 195.3B | 176.6B | 150.4B |
| Total Assets | 309.6B | 298.3B | 273.7B | 245.7B | 212.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 77.4B | 68.6B | 64.4B | 56.8B | 49.1B |
| Short-term Debt | 6.1B | 4.5B | 4.3B | 3.1B | 3.6B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 28.0B | 27.3B | 27.1B | 26.3B | 23.0B |
| Total Current Liabilities | 114.9B | 103.8B | 99.1B | 89.2B | 78.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 72.3B | 72.4B | 58.3B | 54.5B | 42.4B |
| Deferred Tax Liabilities | 2.4B | 3.6B | 3.0B | 2.8B | 3.3B |
| Other Non-Current Liabilities | 18.2B | 15.9B | 14.5B | 12.8B | 11.8B |
| Total Non-Current Liabilities | 93.0B | 91.9B | 75.7B | 70.1B | 57.4B |
| Total Liabilities | 207.9B | 195.7B | 174.8B | 159.4B | 135.7B |
| Equity | |||||
| Common Stock | 9.0M | 9.0M | 9.0M | 9.0M | 10.0M |
| Retained Earnings | 95.6B | 96.0B | 95.8B | 86.2B | 77.1B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 101.7B | 102.6B | 98.9B | 86.3B | 76.5B |
| Key Metrics | |||||
| Total Debt | 78.4B | 76.9B | 62.5B | 57.6B | 46.0B |
| Working Capital | -24.3B | -18.0B | -20.6B | -20.2B | -16.5B |
Balance Sheet Composition
UnitedHealth Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 12.8B | 15.2B | 23.1B | 20.6B | 17.7B |
| Depreciation & Amortization | 4.4B | 4.1B | 4.0B | 3.4B | 3.1B |
| Stock-Based Compensation | 971.0M | 1.0B | 1.1B | 925.0M | 800.0M |
| Working Capital Changes | -3.5B | -3.3B | -1.8B | -3.2B | -2.2B |
| Operating Cash Flow | 13.6B | 13.4B | 25.6B | 20.8B | 18.6B |
| Investing Activities | |||||
| Capital Expenditures | -3.6B | -3.5B | -3.4B | -2.8B | -2.5B |
| Acquisitions | -4.5B | -13.4B | -10.1B | -21.5B | -4.8B |
| Investment Purchases | -17.4B | -27.3B | -18.3B | -18.8B | -17.1B |
| Investment Sales | 17.7B | 27.8B | 16.5B | 12.0B | 15.3B |
| Investing Cash Flow | -8.7B | -20.5B | -15.6B | -28.5B | -10.4B |
| Financing Activities | |||||
| Share Repurchases | -5.5B | -9.0B | -8.0B | -7.0B | -5.0B |
| Dividends Paid | -7.9B | -7.5B | -6.8B | -6.0B | -5.3B |
| Debt Issuance | 3.0B | 17.8B | 6.4B | 14.8B | 6.9B |
| Debt Repayment | -3.0B | -3.0B | -2.1B | -3.0B | -3.2B |
| Financing Cash Flow | -11.6B | -3.5B | -11.5B | 4.2B | -7.5B |
| Free Cash Flow | 16.1B | 20.7B | 25.7B | 23.4B | 19.9B |
| Net Change in Cash | -6.7B | -10.6B | -1.5B | -3.5B | 784.0M |
Cash Flow Trend
UnitedHealth Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
26.81
Forward P/E
17.17
Price to Book
3.42
Price to Sales
0.72
PEG Ratio
-0.27
Profitability Ratios
Profit Margin
2.68%
Operating Margin
8.05%
Return on Equity
12.18%
Return on Assets
3.78%
Financial Health
Current Ratio
0.80
Debt to Equity
73.98
Beta
0.41
Per Share Data
EPS (TTM)
$13.24
Book Value per Share
$103.87
Revenue per Share
$496.37
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| UNH | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
| CVS Health | 101.1B | 55.65 | 1.31 | 2.29% | 0.44% | 106.06 |
| Elevance Health | 76.4B | 13.19 | 1.67 | 13.25% | 2.84% | 74.39 |
| Cigna | 72.7B | 12.61 | 1.77 | 15.13% | 2.17% | 75.14 |
| Humana | 25.8B | 21.84 | 1.47 | 7.04% | 0.92% | 74.82 |
| Centene | 20.2B | 8.06 | 1.01 | -28.68% | -3.79% | 90.56 |
Financial data is updated regularly. All figures are in the company's reporting currency.






